Healthcare


Genetic Technology Alert. Evaluating p53-Based Anti-Cancer Therapies; Simulated Model of Bacterium Creates Waves in Synthetic Biology; Gene Therapy for Lipoprotein Lipase Deficiency

Share this:

This issue profiles evaluating p53-based anti-cancer therapies, gene therapy for lipoprotein lipase deficiency, association of nicotinamide adenine dinucleotide dehydrogenase with skin aging and pigmentation. Strategic partnership details and some important patents have also been included.

Click headings to expand and collapse Published: 27 Jul 2012

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..